Adwya
- Company typePrivate
- Founded1984
- HeadquartersLa Marsa, Tunisia
- Headcount251–500
- GTM typeB2B
- OfferingHardware or Manufacturing
Adwya firmographics
Firmographics- Name
- Adwya
- Legal name
- Laboratoires Adwya
- Website
- https://adwya.com.tn
- Company type
- Private
- Founded year
- 1984
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Ownership category
- akta.pro rank
Adwya industry classification
Industry- Product category
- Generic Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Generic Hospital & Institutional Products (HLAIABAL)
Keywords
Where Adwya is headquartered
LocationHeadquarters
- HQ city
- La Marsa
- HQ country
- Tunisia
- HQ region
- Africa
Offices1 record
Markets served
Adwya business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical product sales: Adwya generates revenue through the manufacture and sale of pharmaceutical products, including licensed medicines produced under licence from major international laboratories, as well as a broad portfolio of branded generics covering multiple therapeutic areas. The company also exports products to Libya, West Africa, and Iraq.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Adwya product offering
Product offeringCore offering
Adwya manufactures and sells pharmaceutical products including a broad portfolio of branded generics covering multiple therapeutic areas and licensed medicines produced under licence from major international laboratories (GSK, Opella, Merck, Beximco, Cooper). The company operates three specialized plants producing dry forms, liquid forms, beta-lactam antibiotics, and sterile products, with a combined capacity of more than 30 million boxes per year, and also develops food supplements. Products are distributed through Tunisian pharmacies and exported to Libya, West Africa, and Iraq.
Product overview
Adwya is a pharmaceutical company offering a unified portfolio of branded generic medicines and licensed pharmaceutical products. The company operates three manufacturing plants (Alpha, Beta, and Gamma) producing dry and liquid pharmaceutical forms including beta-lactam antibiotics and sterile products, with a total production capacity of 30 million boxes per year across 16,500 m². Adwya also develops food supplements. Products are distributed through medical promotion teams across Tunisia and exported to Libya, West Africa, and Iraq.
Differentiator
Problem solved
Functional benefit
Products and services
- Branded Generic Medicines
Companies that use Adwya
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
Adwya technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Adwya partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Adwya competitors and assessment
Company assessmentDirect peers
- Saiph Pharmaceutical: Tunisia-based generic pharmaceutical manufacturer operating in overlapping therapeutic areas. Closely comparable to Adwya as a domestic Tunisian pharma producer serving similar pharmacy and medical channels.
- Laboratoires Ibn Baytar: Historic Tunisian pharmaceutical laboratory producing branded generics across multiple therapeutic categories. Directly comparable as a fellow Tunisian branded-generic manufacturer with overlapping product mix and customer base.
Regional players
- Cooper Pharma: Morocco-based pharmaceutical manufacturer producing generics across multiple therapeutic categories. Comparable as a North African regional peer; Cooper is also an existing licensing partner of Adwya, highlighting the direct competitive and partnership overlap.
- Julphar (Gulf Pharmaceutical Industries): UAE-based pharmaceutical manufacturer producing generics and branded products distributed across the Middle East and Africa. Comparable as a regional MENA generic manufacturer targeting similar export geographies.
- Eva Pharma: Egypt-based pharmaceutical manufacturer with a broad generic and branded portfolio serving MENA and Africa. Comparable as a regional generic pharma manufacturer operating in overlapping therapeutic categories and export markets.
- SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation): Leading Saudi Arabian pharmaceutical manufacturer with branded generics, licensing partnerships, and exports across the MENA region. Comparable as a regional generic manufacturer with a similar licensing-driven product strategy.
- EIPICO (Egyptian International Pharmaceutical Industries Company): One of the largest pharmaceutical manufacturers in Egypt and the MENA region, producing branded generics across multiple therapeutic areas. Comparable as a regional generic pharma incumbent competing in overlapping MENA/African markets.
Broad incumbents
- Hikma Pharmaceuticals: Jordan-headquartered multinational pharmaceutical company with a significant MENA and North African footprint in branded generics and injectables. Comparable as a much larger MENA-focused generic pharma incumbent whose scale defines the competitive ceiling for regional players like Adwya.
- Aspen Pharmacare: South African pharmaceutical giant with a large generic and branded portfolio across Africa and emerging markets. Comparable as a broad African incumbent whose distribution reach and scale set the regional benchmark.
- Sanofi (MENA operations): Global pharmaceutical multinational with a substantial presence across MENA and Africa, including branded generics, vaccines, and licensed production. Comparable as a broad incumbent whose portfolio and scale shape the regional competitive landscape.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Adwya social profiles
Digital presenceAdwya compliance and trust
Trust signalCompliance1 record
Adwya financial estimates
Financial estimateRevenue estimate
Valuation estimate
Adwya leadership team
Management profileNumber of profiles
Adwya funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Adwya M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Adwya
What does Adwya do?
Adwya manufactures and sells pharmaceutical products including a broad portfolio of branded generics covering multiple therapeutic areas and licensed medicines produced under licence from major international laboratories (GSK, Opella, Merck, Beximco, Cooper). The company operates three specialized plants producing dry forms, liquid forms, beta-lactam antibiotics, and sterile products, with a combined capacity of more than 30 million boxes per year, and also develops food supplements. Products are distributed through Tunisian pharmacies and exported to Libya, West Africa, and Iraq.
Is Adwya a public or private company?
Adwya is a private company. It is classified as public and is currently operating.
When was Adwya founded?
Adwya was founded in 1984. It employs 251 to 500 people.
Where is Adwya based?
Adwya is headquartered in La Marsa, Tunisia, in the Africa region.
How does Adwya make money?
One revenue line is on record: pharmaceutical product sales.
Who are Adwya's main competitors?
Direct peers on record are Saiph Pharmaceutical and Laboratoires Ibn Baytar. Regional players are Cooper Pharma, Julphar (Gulf Pharmaceutical Industries), Eva Pharma, SPIMACO (Saudi Pharmaceutical Industries & Medical Appliances Corporation) and EIPICO (Egyptian International Pharmaceutical Industries Company). Broad incumbents are Hikma Pharmaceuticals, Aspen Pharmacare and Sanofi (MENA operations).
Does Adwya have an API?
No public API is recorded for Adwya.
What industry is Adwya in?
Adwya's product category is Generic Pharmaceuticals. Its primary akta.pro industry code is HLAIABAL, Generic Hospital & Institutional Products. Its NAICS code is 325412 and its SIC code is 2834.